Navigation Links
Halo XP 20 Pole Deflectable Catheter

ProductsHalo XP 20 Pole Deflectable Catheter
Company Biosense Webster, a Johnson & Johnson Company
Item Halo XP 20 Pole Deflectable Catheter
Features 
  • 2-13-2 mm spacing (on P15-FS) allows positioning over a large area of the atrium
  • Pair of electrodes (on P15-FS) at the distal tip permit pacing in the CS
  • Angular-shaped tip permits easy insertion in the CS ostium
  • 20 platinum iridium electrodes produce high-fidelity electrograms and permit simultaneous electrogram recording of the tricuspid valve annulus without catheter repositioning
  • Exceptional torqueability and tip stability
  • Description For Tricuspid Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters for mapping in the atrium. The HALO XP 20-pole deflectable catheter is designed for simple placement and mapping around the tricuspid annulus. The pair of electrodes located on the catheter's distal tip (on P15-FS/0 permit pacing in the coronary sinus (CS) for confirmation of conduction block.
    Info Biosense Webster, a Johnson & Johnson Company
    Customer Service: (800) 729-9010
    Web site: http://www.biosensewebster.com/

    Related medicine products :

    1. Webster Small Anatomy Deflectable Catheters
    2. Webster Coronary Sinus Deflectable Catheters
    3. Webster Quadripolar Standard Deflectable Catheters
    4. Webster Octapolar Standard Deflectable Catheters
    5. Webster Quadrapolar Standard Deflectable Catheters
    6. Webster Decapolar Standard Deflectable Catheters
    7. Webster Decapolar Coronary Sinus Deflectable Catheters
    8. Webster Hexapolar Standard Deflectable Catheters
    9. Webster Crista Cath 20-Pole Deflectable Catheter
    10. Webster Ismus Cath 20-Pole Deflectable Catheter
    11. Webster Porterfield Deflectable Catheter
    Prolactin EIA Reproductive Markers 025-BC-1037...
    LH EIA Reproductive Markers 025-BC-1031 Luteinizing Hormone...
    ... principle of a competitive enzyme immunoassay where ... and an labelled antigen bound to the ... . The amount of enzyme conjugate complex ... is inversely proportional to the concentration of ...
    ... (5-Androstene-3-0L-17-one,Androstenolone, Dehydroisoandrosterone,Transdehydroandrosterone, DHEA) is a ... mostly in its,sulfate form (DHEA-S). ... based on the competition principle ... amount of DHEA-S present in ...
    Medicine Products:
    (Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
    (Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
    (Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
    (Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
    Breaking Medicine News(10 mins):
    (Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
    (Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
    (Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
    Breaking Medicine Technology: